tykhr
sign in
free sign up
Novo Nordisk A S
Drug Manufacturers - General
Healthcare
NVO
4.45 B shares
NYSE US
traded
23 Sep 2025
listed
no
open
60.30
52 week high
137.00
high
60.33
52 week low
0.00
low
59.08
growth
-53.31 %
previous Close
60.71
P/E ratio
9
market cap
305 B
div yield
0
usd
Mar 2025
qoq
revenue
78.09 B
-8.87 %
net incoming
29.03 B
2.85 %
eps
6.53 %
3.00 %
eps surprise
7.58 %
net profit margin
37.18 %
4.00 %
operating incoming
38.79 B
5.59 %
net change in cash
23.28 B
156.29 %
cash on hand
38.94 B
148.73 %
cost of revenue
12.89 B
-1.03 %
top